Failure of the symbiot PTFE-covered tent to reduce distal embolization uring percutaneous coronary intervention in saphenous vein grafts

Journal of Invasive Cardiology

Volumn 17, Issue 11, 2005, Pages 609-612

  Blackman, Daniel J ^a   Choudhury, Robin P ^a   Banning, Adrian P ^a   Channon, Keith M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

FORMALDEHYDE; POLITEF;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; ARTIFICIAL EMBOLISM; BALLOON DILATATION; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY STENT; EMBOLISM; GUIDE WIRE; HUMAN; INCIDENCE; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PHOTOGRAPHY; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SAPHENOUS VEIN GRAFT;

AGED; ANGINA PECTORIS; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CONSTRICTION, PATHOLOGIC; CORONARY ARTERY BYPASS; CORONARY RESTENOSIS; EMBOLISM; FEMALE; GRAFT OCCLUSION, VASCULAR; HUMANS; MALE; MIDDLE AGED; POLYTETRAFLUOROETHYLENE; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; SAPHENOUS VEIN; STENTS;

EID: 33646006131     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Fitzgibbon GM, Kafka HP, Leach AJ, et al. Coronary bypass graft fate and patient outcome: angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years. J Am Coll Cardiol 1996;28:616-626.
2. Hong MK, Mehran R, Dangas G, et al. Are we making progress with percutaneous saphenous vein graft treatment? A comparison of 1990 to 1994 and 1995 to 1998 results. J Am Coll Cardiol 2001;38:150-154.
3. Hong MK, Mehran R, Dangas G, et al. Creatine kinase-MB enzyme elevation following successful saphenous vein graft intervention is associated with late mortality. Circulation 1999;100:2400-2405.
4. Baim DS, Wahr D, George B, et al. Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts. Circulation 2002;105:13-18.
5. Stone GW, Rogers C, Hermiller J, et al. Randomized comparison of distal protection with a filterbased catheter and a balloon occlusion and aspiration system during percutaneous intervention of diseased saphenous vein aortocoronary bypass grafts. Circulation 2003;108:548-553.
6. Stankovic G, Colombo A, Presbitero P, et al. Randomized evaluation of polytetrafluoroethylene-covered stent in saphenous vein grafts: The Randomized Evaluation of polytetrafluoroethylene COVERed stent in Saphenous vein grafts (RECOVERS) Trial. Circulation 2003;108:37-42.
7. Schachinger V, Hamm CW, Munzel T, et al. A randomized trial of polytetrafluoroethylene-membrane-covered stents compared with conventional stents in aortocoronary saphenous vein grafts. J Am Coll Cardiol 2003;42:1360-1369.
8. Stone GW, Goldberg S, Mehran R, et al. A prospective, randomized U.S. trial of the PTFE covered JOSTENT for the treatment of diseased saphenous vein grafts: the BARRICADE trial (Abstr). J Am Coll Cardiol 2005;45:27A.
9. Buchbinder M, Turco M, on behalf of the SYMBIOT III investigators. 8 months results from the Symbiot III randomized SVG trial. Presented at Transcatheter Cardiovascular Therapeutics 2004, Washington DC.
10. Grube E, Schofer J, Webb J, et al. Evaluation of a balloon occlusion and aspiration system for protection from distal embolization during stenting in saphenous vein grafts. Am J Cardiol 2002;89:941-945.
11. Popma JJ, Cox N, Hauptmann KE, et al. Initial clinical experience with distal protection using the FilterWire in patients undergoing coronary artery and saphenous vein graft percutaneous intervention. Catheter Cardiovasc Interv 2002;57:125-134.